1802-12-6 Usage
Description
Phytolaccagenin, with the CAS number 1802-12-6, is a saponin compound derived from the Phytolacca acinosa and Phytolacca americana plant species. It is known for its antiproliferative activities in humans, making it a potential candidate for various applications in the pharmaceutical and healthcare industries.
Uses
Used in Pharmaceutical Applications:
Phytolaccagenin is used as a bioactive compound for its antiproliferative properties in humans. It has the potential to be developed into a pharmaceutical agent targeting the inhibition of cell proliferation, which could be beneficial in treating various diseases and conditions related to uncontrolled cell growth.
Used in Cancer Research:
Phytolaccagenin is used as a research tool for studying the mechanisms behind its antiproliferative activities. This can help in understanding its potential role in cancer treatment and prevention, as well as in the development of new therapeutic strategies against cancer.
Used in Traditional Medicine:
Phytolaccagenin is used in traditional medicine practices, where the Phytolacca plant has been utilized for its various health benefits. The compound may be incorporated into herbal remedies and supplements for promoting overall health and well-being.
Used in Drug Delivery Systems:
Similar to gallotannin, Phytolaccagenin could be used in the development of novel drug delivery systems to enhance its applications and efficacy against specific health conditions. This may involve the use of organic and metallic nanoparticles as carriers for improved delivery, bioavailability, and therapeutic outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 1802-12-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,0 and 2 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1802-12:
(6*1)+(5*8)+(4*0)+(3*2)+(2*1)+(1*2)=56
56 % 10 = 6
So 1802-12-6 is a valid CAS Registry Number.
InChI:InChI=1/C31H48O7/c1-26(25(37)38-6)11-13-31(24(35)36)14-12-29(4)18(19(31)15-26)7-8-22-27(2)16-20(33)23(34)28(3,17-32)21(27)9-10-30(22,29)5/h7,19-23,32-34H,8-17H2,1-6H3,(H,35,36)
1802-12-6Relevant articles and documents
Synthesis of novel derivatives of esculentoside A and its aglycone phytolaccagenin, and evaluation of their haemolytic activity and inhibition of lipopolysaccharide-induced nitric oxide production
Gong, Wei,Jiang, Zhihui,Sun, Peng,Li, Ling,Jin, Yongsheng,Shao, Lucheng,Zhang, Wen,Liu, Baoshu,Zhang, Hongwei,Tang, Hua,Chen, Yufeng,Yi, Yanghua,Zhang, Dazhi
experimental part, p. 1833 - 1852 (2012/01/14)
A series of 46 compounds derived from esculentoside A and its aglycone were synthesized and characterized. The effect of these compounds on lipopolysaccharide (LPS)-induced NO production, haemolytic activity, and cell viability was evaluated. Structure-ac
METHODS AND COMPOSITIONS RELATED TO AGLYCOSIDIC ESCULENTOSIDE A
-
Page/Page column 45, (2009/12/27)
Disclosed are compositions related to water soluble selective COX-2 inhibitors and methods of using the inhibitors (including h-EsA and derivatives thereof.)
